P004 - Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients

Autor: Petrakova, K., Petruzelka, L., Holanek, M., Svoboda, T., Benesova, V., Palacova, M., Kolarova, I., Bielcikova, Z., Chrapava, M.
Zdroj: In The Breast March 2019 44 Supplement 1:S16-S16
Databáze: ScienceDirect
Externí odkaz: